MeiraGTx/$MGTX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About MeiraGTx
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
Ticker
$MGTX
Sector
Primary listing
Employees
409
Headquarters
Website
MeiraGTx Metrics
BasicAdvanced
$624M
-
-$2.11
-
-
Price and volume
Market cap
$624M
52-week high
$9.73
52-week low
$4.55
Average daily volume
513K
Financial strength
Current ratio
0.223
Quick ratio
0.174
Long term debt to equity
-28.432
Total debt to equity
-217.129
Interest coverage (TTM)
-13.06%
Profitability
EBITDA (TTM)
-151.432
Gross margin (TTM)
41.01%
Net profit margin (TTM)
-615.27%
Operating margin (TTM)
-597.91%
Revenue per employee (TTM)
$70,000
Management effectiveness
Return on assets (TTM)
-41.91%
Return on equity (TTM)
-611.42%
Valuation
Price to revenue (TTM)
22.596
Price to book
-15.38
Price to tangible book (TTM)
-15.14
Price to free cash flow (TTM)
-5.118
Free cash flow yield (TTM)
-19.54%
Free cash flow per share (TTM)
-1.514
Growth
Revenue change (TTM)
96.83%
Earnings per share change (TTM)
57.02%
3-year revenue growth (CAGR)
-13.42%
3-year earnings per share growth (CAGR)
-5.74%
What the Analysts think about MeiraGTx
Analyst ratings (Buy, Hold, Sell) for MeiraGTx stock.
MeiraGTx Financial Performance
Revenues and expenses
MeiraGTx Earnings Performance
Company profitability
MeiraGTx News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MeiraGTx stock?
MeiraGTx (MGTX) has a market cap of $624M as of November 19, 2025.
What is the P/E ratio for MeiraGTx stock?
The price to earnings (P/E) ratio for MeiraGTx (MGTX) stock is 0 as of November 19, 2025.
Does MeiraGTx stock pay dividends?
No, MeiraGTx (MGTX) stock does not pay dividends to its shareholders as of November 19, 2025.
When is the next MeiraGTx dividend payment date?
MeiraGTx (MGTX) stock does not pay dividends to its shareholders.
What is the beta indicator for MeiraGTx?
MeiraGTx (MGTX) does not currently have a Beta indicator.